West Pharmaceutical Services

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell WST and other ETFs, options, and stocks.

About WST

West Pharmaceutical Services, Inc. engages in the design, manufacture, and sale of containment and delivery systems for injectable drugs and healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. 

CEO
Eric Mark Green
CEOEric Mark Green
Employees
10,800
Employees10,800
Headquarters
Exton, Pennsylvania
HeadquartersExton, Pennsylvania
Founded
1923
Founded1923
Employees
10,800
Employees10,800

WST Key Statistics

Market cap
23.68B
Market cap23.68B
Price-Earnings ratio
48.45
Price-Earnings ratio48.45
Dividend yield
0.24%
Dividend yield0.24%
Average volume
1.02M
Average volume1.02M
High today
$337.57
High today$337.57
Low today
$334.37
Low today$334.37
Open price
$336.35
Open price$336.35
Volume
65.15K
Volume65.15K
52 Week high
$386.00
52 Week high$386.00
52 Week low
$223.83
52 Week low$223.83

Stock Snapshot

With a market cap of 23.68B, West Pharmaceutical Services(WST) trades at $335.21. The stock has a price-to-earnings ratio of 48.45 and currently yields dividends of 0.24%.

As of 2026-07-30, West Pharmaceutical Services(WST) stock has fluctuated between $334.37 and $337.57. The current price stands at $335.21, placing the stock +0.3% above today's low and -0.7% off the high.

The West Pharmaceutical Services(WST)'s current trading volume is 65.15K, compared to an average daily volume of 1.02M.

During the past year, West Pharmaceutical Services(WST) stock moved between $223.83 at its lowest and $386.00 at its peak.

During the past year, West Pharmaceutical Services(WST) stock moved between $223.83 at its lowest and $386.00 at its peak.

WST News

Simply Wall St 2d
West Pharmaceutical Services Is Down 6.0% After Raising 2026 Outlook and Expanding Daikyo Deal

West Pharmaceutical Services recently reported second-quarter 2026 results showing higher sales and earnings than a year earlier, raised its full-year 2026 reve...

West Pharmaceutical Services Is Down 6.0% After Raising 2026 Outlook and Expanding Daikyo Deal
TipRanks 3d
West Pharmaceutical price target raised to $425 from $410 at Evercore ISI

Evercore ISI raised the firm’s price target on West Pharmaceutical (WST) to $425 from $410 and keeps an Outperform rating on the shares. Unlock powerful invest...

TipRanks 7d
West Pharmaceutical lifts guidance on HVP-driven surge

West Pharmaceutical Services, Inc. ((WST)) has held its Q2 earnings call. Read on for the main highlights of the call. Claim 55% Off TipRanks Unlock powerful in...

Analyst ratings

84%

of 19 ratings
Buy
84.2%
Hold
15.8%
Sell
0%

More WST News

Benzinga 7d
West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

Net sales of $872.3 million increased 13.8% year over year, with organic growth of 12.7%, beating the consensus of $838.586 million. HVP Products And GLP-1 Dem...

West Pharmaceutical CEO Highlights GLP-1 And Biologics Momentum

People also own

Based on the portfolios of people who own WST. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.